{"transactions":[{"id":741778,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T20:15:20.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":10.55,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001754129-26-000006","document":"form4-06112026_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000175412926000006/form4-06112026_040607.xml","form_type":"4"}},{"id":751856,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:04:31.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":1593,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1593},"source":{"system":"sec-edgar","filing":"0001193125-26-256124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000119312526256124/ownership.xml","form_type":"4"}},{"id":751855,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-04T01:04:31.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":10507,"derivative":{"exercise_price":53.46,"expiration_date":"2036-06-02","underlying":"Common Shares","underlying_shares":10507},"source":{"system":"sec-edgar","filing":"0001193125-26-256124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000119312526256124/ownership.xml","form_type":"4"}},{"id":751854,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:04:31.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0001193125-26-256124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000119312526256124/ownership.xml","form_type":"4"}},{"id":751853,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-04T01:04:31.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":2645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"source":{"system":"sec-edgar","filing":"0001193125-26-256124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000119312526256124/ownership.xml","form_type":"4"}},{"id":758826,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-05-29T21:17:32.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":21110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21110,"derivative":{"exercise_price":11.85,"exercise_date":"2027-05-27","expiration_date":"2036-05-26","underlying":"Ordinary Shares","underlying_shares":21110},"source":{"system":"sec-edgar","filing":"0001754129-26-000004","document":"wk-form4_1780089449.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000175412926000004/wk-form4_1780089449.xml","form_type":"4"}},{"id":951751,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:10:23.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025."}],"balance_after":45000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001754129-26-000002","document":"form4-01052026_090117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000175412926000002/form4-01052026_090117.xml","form_type":"4"}},{"id":1044061,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-09-10T21:18:17.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":15833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over 12 months following September 9, 2025."}],"balance_after":15833,"derivative":{"exercise_price":6.64,"expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":15833},"source":{"system":"sec-edgar","filing":"0001415889-25-024109","document":"form4-09102025_090913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925024109/form4-09102025_090913.xml","form_type":"4"}},{"id":1044060,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-09-10T21:18:17.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025."}],"balance_after":30000,"derivative":{"exercise_price":6.64,"expiration_date":"2035-09-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-024109","document":"form4-09102025_090913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925024109/form4-09102025_090913.xml","form_type":"4"}},{"id":1079193,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-07-30T20:25:59.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on August 29, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":52000,"derivative":{"exercise_price":4.29,"exercise_date":"2025-08-29","expiration_date":"2035-07-28","underlying":"Ordinary Shares","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001816590-25-000099","document":"wk-form4_1753907148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000099/wk-form4_1753907148.xml","form_type":"4"}},{"id":1119759,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-06T21:59:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000950170-25-083325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000095017025083325/ownership.xml","form_type":"4"}},{"id":1119758,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-06T21:59:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":17012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":17012,"derivative":{"exercise_price":30.73,"expiration_date":"2035-06-04","underlying":"Common Shares","underlying_shares":17012},"source":{"system":"sec-edgar","filing":"0000950170-25-083325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000095017025083325/ownership.xml","form_type":"4"}},{"id":1490121,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:42:40.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":15542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders."}],"balance_after":15542,"derivative":{"exercise_price":38.16,"expiration_date":"2034-06-04","underlying":"Common Shares","underlying_shares":15542},"source":{"system":"sec-edgar","filing":"0000950170-24-069466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000095017024069466/ownership.xml","form_type":"4"}},{"id":1810901,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-10T23:05:25.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the \"Start Date\"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date."}],"balance_after":28000,"derivative":{"exercise_price":38.39,"expiration_date":"2033-08-09","underlying":"Common Shares","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000950170-23-041534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000095017023041534/ownership.xml","form_type":"4"}},{"id":2723323,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":263184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":263184},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723322,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":164496,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Transaction Agreement, one-third of these share options vested and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration, and the remaining two-thirds were converted into an option to acquire Jazz ordinary shares (with any performance goals deemed fully satisfied), half of which will vest on March 2, 2022 and half of which will vest on March 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":164496},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723321,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":479844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":479844},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723320,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":287904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":287904},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723319,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":55488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":55488},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723318,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":12492,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":12492},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723317,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":226752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":226752},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723316,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":34008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":34008},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723315,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":22440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These stock options were granted with automatic vesting on exercisable date."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"underlying":"Ordinary Shares","underlying_shares":22440},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723314,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":30936,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":14.645,"expiration_date":"2029-06-14","underlying":"Ordinary Shares","underlying_shares":30936},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723313,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":119472,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":14.3342,"expiration_date":"2029-03-01","underlying":"Ordinary Shares","underlying_shares":119472},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723312,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":147624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":9.6092,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":147624},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723311,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":142344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":9.8117,"expiration_date":"2027-01-06","underlying":"Ordinary Shares","underlying_shares":142344},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723310,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":213240,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":3.72,"expiration_date":"2026-02-15","underlying":"Ordinary Shares","underlying_shares":213240},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723309,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":75864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":10.605,"expiration_date":"2025-06-24","underlying":"Ordinary Shares","underlying_shares":75864},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723308,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":17508,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Transaction Agreement, dated as of February 3, 2021 (the \"Transaction Agreement\"), by and among the Company, Jazz and Bidco, these share options vested (to the extent unvested) and were canceled in connection with the closing of the transactions contemplated by the Transaction Agreement in exchange for an all-cash payment equal to the value of the share options based on the value of the transaction consideration."}],"balance_after":0,"derivative":{"exercise_price":0.0017,"expiration_date":"2022-03-15","underlying":"Ordinary Shares","underlying_shares":17508},"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723307,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":1867308,"ownership":{"direct":false,"nature":"By the Gover Family Investment LLP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723306,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":456048,"ownership":{"direct":false,"nature":"By Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2723305,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-07T20:15:42.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":222773,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 5, 2021, Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in the Republic of Ireland (\"Jazz\"), Jazz Pharmaceuticals UK Holdings Limited, a private limited company incorporated in England and Wales and an indirect wholly owned subsidiary of Jazz (\"Bidco\") and the DR Nominee (as defined in the Transaction Agreement) acquired all outstanding ordinary shares, par value British Pound Sterling 0.001 per share, of GW Pharmaceuticals plc, a public limited company incorporated in England and Wales (the \"Company\"), by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\") (continued in footnote 2)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Scheme of Arrangement, Scheme Shareholders (as defined in the Scheme of Arrangement) became entitled to receive for each Scheme Share (as defined in the Scheme of Arrangement) held by them an amount equal to $16.66 2/3 in cash plus 0.010030 ordinary shares, nominal value $0.0001 per share, of Jazz (\"Jazz ordinary shares\"). The transaction is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on March 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-018659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321018659/doc4.xml","form_type":"4"}},{"id":2776359,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-23T00:00:12.000Z","date":"2021-03-19","kind":"gift","acquired":false,"shares":276000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Gover Family Investment LLP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of ordinary shares in the form of American Depositary Shares."}],"balance_after":1867308,"source":{"system":"sec-edgar","filing":"0000899243-21-012950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321012950/doc4.xml","form_type":"4"}},{"id":2809085,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-05T02:04:18.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":164496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"security","element":"securityTitle","label":"F6","text":"The share numbers underlying options granted on February 22, 2021 and reported on the reporting person's form 4 filed on February 24, 2021 were amended as of March 2, 2021 and as reported in this form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":164496,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":164496},"source":{"system":"sec-edgar","filing":"0000899243-21-010020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321010020/doc4.xml","form_type":"4"}},{"id":2809084,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-05T02:04:18.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":263184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"security","element":"securityTitle","label":"F6","text":"The share numbers underlying options granted on February 22, 2021 and reported on the reporting person's form 4 filed on February 24, 2021 were amended as of March 2, 2021 and as reported in this form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":263184,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":263184},"source":{"system":"sec-edgar","filing":"0000899243-21-010020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321010020/doc4.xml","form_type":"4"}},{"id":2820801,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-03T02:27:57.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":17004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of March 1, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-03-01","expiration_date":"2021-03-01","underlying":"Ordinary Shares","underlying_shares":17004},"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820800,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":101436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":101436},"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820799,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":24,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":24},"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820798,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":299196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":299196},"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820797,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":22440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0014,"exercise_date":"2021-02-26","expiration_date":"2021-02-26","underlying":"Ordinary Shares","underlying_shares":22440},"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820796,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":8412,"price":17.85,"value":150154.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":222773,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820795,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":17004,"price":0.0014,"value":23.8056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":231185,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820794,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":49992,"price":17.9,"value":894856.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":214181,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820793,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":101412,"price":0.0014,"value":141.9768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":264173,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820792,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":12,"price":17.9,"value":214.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":162761,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820791,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":24,"price":0.0014,"value":0.0336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":162773,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820790,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":147806,"price":17.9,"value":2645727.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":162749,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820789,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":299196,"price":0.0014,"value":418.8744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":310555,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820788,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":11086,"price":17.9,"value":198439.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":11359,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2820787,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-03T02:27:57.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":22440,"price":0.0014,"value":31.416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of share options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.39 U.S. Dollars as of February 26, 2021."}],"balance_after":22445,"source":{"system":"sec-edgar","filing":"0000899243-21-009215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321009215/doc4.xml","form_type":"4"}},{"id":2836082,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-02-24T23:49:30.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":263184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on February 22, 2022 and be automatically exercised upon vesting"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":263184,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":263184},"source":{"system":"sec-edgar","filing":"0000899243-21-008093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321008093/doc4.xml","form_type":"4"}},{"id":2836081,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2021-02-24T23:49:30.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":164496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on February 22, 2024 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc."}],"balance_after":164496,"derivative":{"exercise_price":0.0014,"underlying":"Ordinary Shares","underlying_shares":164496},"source":{"system":"sec-edgar","filing":"0000899243-21-008093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321008093/doc4.xml","form_type":"4"}},{"id":2916123,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-07T02:01:16.000Z","date":"2020-12-31","kind":"gift","acquired":true,"shares":456048,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust."}],"balance_after":456048,"source":{"system":"sec-edgar","filing":"0000899243-21-000774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321000774/doc4.xml","form_type":"4"}},{"id":2916122,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-01-07T02:01:16.000Z","date":"2020-12-31","kind":"gift","acquired":false,"shares":456048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust."}],"balance_after":5,"source":{"system":"sec-edgar","filing":"0000899243-21-000774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924321000774/doc4.xml","form_type":"4"}},{"id":2977849,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":42708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.33 U.S. Dollars as of November 17, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":101409,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-01-06","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":42708},"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977848,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":22800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 16, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":144117,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-01-06","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":22800},"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977847,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-13","kind":"exercise","acquired":false,"shares":3924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 13, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":10,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-02-15","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":3924},"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977846,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-13","kind":"exercise","acquired":false,"shares":39060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 13, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":166917,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-01-06","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":39060},"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977845,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":42708,"price":10.03,"value":428361.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price per ordinary share ($120.3923 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.85 per ADS (or $10.07 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":456053,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977844,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":42708,"price":0.0013,"value":55.5204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 16, 2020."}],"balance_after":498761,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977843,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":22800,"price":10.02,"value":228456.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price per ordinary share ($120.2065 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.49 per ADS (or $10.04 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":456053,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977842,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":22800,"price":0.0013,"value":29.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 16, 2020."}],"balance_after":478853,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977841,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":42984,"price":10.01,"value":430269.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($120.1533 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.99 per ADS (or $10.08 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":456053,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977840,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-13","kind":"exercise","acquired":true,"shares":3924,"price":0.0013,"value":5.1012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 13, 2020."}],"balance_after":499037,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2977839,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-18T02:00:35.000Z","date":"2020-11-13","kind":"exercise","acquired":true,"shares":39060,"price":0.0013,"value":50.778,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 13, 2020."}],"balance_after":495113,"source":{"system":"sec-edgar","filing":"0000899243-20-031340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320031340/doc4.xml","form_type":"4"}},{"id":2984073,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"exercise","acquired":false,"shares":27591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 12, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":205977,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-01-06","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":27591},"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984072,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"exercise","acquired":false,"shares":13917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 12, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-01-06","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":13917},"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984071,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"exercise","acquired":false,"shares":22800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 12, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":3934,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-02-15","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":22800},"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984070,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-09","kind":"exercise","acquired":false,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 9, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":13917,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-01-06","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984069,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-09","kind":"exercise","acquired":false,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 9, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":26734,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-02-15","expiration_date":"2021-03-15","underlying":"Ordinary Shares","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984068,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":64308,"price":10.01,"value":643723.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price per ordinary share ($120.1715 per ADS). These shares were sold in multiple transactions at prices ranging from $120.00 per ADS (or $10.00 per ordinary share) to $120.46 per ADS (or $10.04 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":456053,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984067,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"exercise","acquired":true,"shares":27591,"price":0.0013,"value":35.8683,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 12, 2020."}],"balance_after":520361,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984066,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"exercise","acquired":true,"shares":13917,"price":0.0013,"value":18.0921,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 12, 2020."}],"balance_after":492770,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984065,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-12","kind":"exercise","acquired":true,"shares":22800,"price":0.0013,"value":29.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 12, 2020."}],"balance_after":478853,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984064,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":7200,"price":10,"value":72000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":456053,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984063,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-09","kind":"exercise","acquired":true,"shares":3600,"price":0.0013,"value":4.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 9, 2020."}],"balance_after":463253,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":2984062,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-13T02:00:10.000Z","date":"2020-11-09","kind":"exercise","acquired":true,"shares":3600,"price":0.0013,"value":4.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of November 9, 2020."}],"balance_after":459653,"source":{"system":"sec-edgar","filing":"0000899243-20-030883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320030883/doc4.xml","form_type":"4"}},{"id":3107348,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-06-18T00:00:29.000Z","date":"2020-06-15","kind":"exercise","acquired":false,"shares":4164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.25 U.S. Dollars as of June 15, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"exercise_date":"2020-06-15","expiration_date":"2020-06-15","underlying":"Ordinary Shares","underlying_shares":4164},"source":{"system":"sec-edgar","filing":"0000899243-20-016919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320016919/doc4.xml","form_type":"4"}},{"id":3107347,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-06-18T00:00:29.000Z","date":"2020-06-15","kind":"tax_withholding","acquired":false,"shares":2076,"price":10.23,"value":21237.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Mandatory withhold to cover vested RSU style share options."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represented by ADS."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":456053,"source":{"system":"sec-edgar","filing":"0000899243-20-016919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320016919/doc4.xml","form_type":"4"}},{"id":3107346,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-06-18T00:00:29.000Z","date":"2020-06-15","kind":"exercise","acquired":true,"shares":4164,"price":0.0013,"value":5.4132,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options.  Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.25 U.S. Dollars as of June 15, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Column 5 of Table I of the reporting person's form 4 filed with the SEC on March 4, 2020 includes 112,548 ordinary shares underlying RSU style share options pursuant to the Issuer's Long-Term Incentive Plan, including (i) 44,880 ordinary shares vesting automatically in two equal installments on February 26, 2021 and 2022, (ii) 51,012 ordinary shares vesting automatically in three equal installments on March 1, 2021, 2022, and 2023, and (iii) 16,656 ordinary shares vesting automatically in four equal installments on June 14, 2020, 2021, 2022, and 2023.  These ordinary shares have been excluded from Column 5 of this form 4 and will be reported as each tranche is vested and automatically exercised."}],"balance_after":458129,"source":{"system":"sec-edgar","filing":"0000899243-20-016919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320016919/doc4.xml","form_type":"4"}},{"id":3118933,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2020-06-09T00:02:53.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":287904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These share options will vest in four equal annual installments beginning on June 4, 2021 and be automatically exercised upon vesting."}],"balance_after":287904,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":287904},"source":{"system":"sec-edgar","filing":"0000899243-20-015693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320015693/doc4.xml","form_type":"4"}},{"id":3118932,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options","published_at":"2020-06-09T00:02:53.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":479.844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.26 U.S. Dollars as of June 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest and be automatically exercised on June 4, 2023 if certain performance conditions are satisfied."}],"balance_after":479.844,"derivative":{"exercise_price":0.0013,"underlying":"Ordinary Shares","underlying_shares":479.844},"source":{"system":"sec-edgar","filing":"0000899243-20-015693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320015693/doc4.xml","form_type":"4"}},{"id":3227922,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-03-04T23:01:48.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":17510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.28 U.S. Dollars as of March 2, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":7,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-01-06","expiration_date":"2020-03-15","underlying":"Ordinary Shares","underlying_shares":17510},"source":{"system":"sec-edgar","filing":"0000899243-20-006995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006995/doc4.xml","form_type":"4"}},{"id":3227921,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-03-04T23:01:48.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":30334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.28 U.S. Dollars as of March 2, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-02-15","expiration_date":"2020-03-15","underlying":"Ordinary Shares","underlying_shares":30334},"source":{"system":"sec-edgar","filing":"0000899243-20-006995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006995/doc4.xml","form_type":"4"}},{"id":3227920,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T23:01:48.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":8400,"price":8.4,"value":70560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Automatic sale to cover vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":566513,"source":{"system":"sec-edgar","filing":"0000899243-20-006995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006995/doc4.xml","form_type":"4"}},{"id":3227919,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T23:01:48.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":24456,"price":8.31,"value":203229.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale to cover exercise of stock options expiring on March 15, 2020."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":574913,"source":{"system":"sec-edgar","filing":"0000899243-20-006995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006995/doc4.xml","form_type":"4"}},{"id":3227918,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T23:01:48.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":17510,"price":0.0013,"value":22.763,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.28 U.S. Dollars as of March 2, 2020."}],"balance_after":599369,"source":{"system":"sec-edgar","filing":"0000899243-20-006995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006995/doc4.xml","form_type":"4"}},{"id":3227917,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-03-04T23:01:48.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":30334,"price":0.0013,"value":39.4342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.28 U.S. Dollars as of March 2, 2020."}],"balance_after":581859,"source":{"system":"sec-edgar","filing":"0000899243-20-006995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006995/doc4.xml","form_type":"4"}},{"id":3241428,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T23:02:20.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":876,"price":9.21,"value":8067.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":551525,"source":{"system":"sec-edgar","filing":"0000899243-20-006328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006328/doc4.xml","form_type":"4"}},{"id":3241427,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T23:02:20.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":1644,"price":9.17,"value":15075.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":552401,"source":{"system":"sec-edgar","filing":"0000899243-20-006328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006328/doc4.xml","form_type":"4"}},{"id":3241426,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-28T23:02:20.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":9480,"price":9.01,"value":85414.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic sale of vested restricted stock units that have been previously reported in Column 5 of Table I."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represented by American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is price per ordinary share converted from price per ADS."}],"balance_after":554045,"source":{"system":"sec-edgar","filing":"0000899243-20-006328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320006328/doc4.xml","form_type":"4"}},{"id":3288975,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2020-02-05T22:00:23.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":202224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.30 U.S. Dollars as of February 3, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."}],"balance_after":7,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-02-15","expiration_date":"2020-03-15","underlying":"Ordinary Shares","underlying_shares":202224},"source":{"system":"sec-edgar","filing":"0000899243-20-003296","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320003296/doc4.xml","form_type":"4"}},{"id":3288974,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-05T22:00:23.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":19548,"price":9.71,"value":189811.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2019."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price per ordinary share ($116.54 per ADS). These share were sold in multiple transactions at prices ranging from $9.68 per ordinary share ($116.19 per ADS) to $9.76 per ordinary share ($117.07 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":563525,"source":{"system":"sec-edgar","filing":"0000899243-20-003296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320003296/doc4.xml","form_type":"4"}},{"id":3288973,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-05T22:00:23.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":110964,"price":9.63,"value":1068583.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2019."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price per ordinary share ($115.52 per ADS). These share were sold in multiple transactions at prices ranging from $9.60 per ordinary share ($115.16 per ADS) to $9.68 per ordinary share ($116.14 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":583073,"source":{"system":"sec-edgar","filing":"0000899243-20-003296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320003296/doc4.xml","form_type":"4"}},{"id":3288972,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-05T22:00:23.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":71712,"price":9.57,"value":686283.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2019."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price per ordinary share ($114.85 per ADS). These share were sold in multiple transactions at prices ranging from $9.51 per ordinary share ($114.16 per ADS) to $9.60 per ordinary share ($115.15 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":694037,"source":{"system":"sec-edgar","filing":"0000899243-20-003296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320003296/doc4.xml","form_type":"4"}},{"id":3288971,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-05T22:00:23.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":202224,"price":0.0013,"value":262.8912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares (\"ADS\") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.30 U.S. Dollars as of February 3, 2020."}],"balance_after":765749,"source":{"system":"sec-edgar","filing":"0000899243-20-003296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924320003296/doc4.xml","form_type":"4"}},{"id":3335231,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2019-12-19T22:02:27.000Z","date":"2019-12-17","kind":"exercise","acquired":false,"shares":10668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of December 17, 2019."}],"balance_after":11,"derivative":{"exercise_price":0.0013,"exercise_date":"2019-06-24","expiration_date":"2019-12-24","underlying":"Ordinary Shares","underlying_shares":10668},"source":{"system":"sec-edgar","filing":"0000899243-19-029665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924319029665/doc4.xml","form_type":"4"}},{"id":3335230,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-12-19T22:02:27.000Z","date":"2019-12-17","kind":"sale","acquired":false,"shares":5340,"price":9.17,"value":48967.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2019."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represented by ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a price per ordinary share converted from price per ADS."}],"balance_after":563525,"source":{"system":"sec-edgar","filing":"0000899243-19-029665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924319029665/doc4.xml","form_type":"4"}},{"id":3335229,"issuer":{"id":139616,"kind":"organization","name":"GW PHARMACEUTICALS PLC","symbol":"GWPH"},"owners":[{"id":39300,"kind":"person","name":"Gover Justin D.","position":1,"cik":"0001754129","reported_name":"Gover Justin D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-12-19T22:02:27.000Z","date":"2019-12-17","kind":"exercise","acquired":true,"shares":10668,"price":0.0013,"value":13.8684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise of stock options. Following the exercise, these  shares were converted into American Depositary Shares of the Issuer (\"ADS\"). Each ADS represents twelve ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of December 17, 2019."}],"balance_after":568865,"source":{"system":"sec-edgar","filing":"0000899243-19-029665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754129/000089924319029665/doc4.xml","form_type":"4"}}],"next_cursor":"2019-12-19T22:02:27.000000Z,3335229"}